Cost-Containment

The CEOs of Merck, Bristol Myers Squibb and Johnson & Johnson faced a barrage of questions on Capitol Hill from Sen. Bernie Sanders (I-VT) and other members of the Health, Education, Labor and Pensions committee.

The Delinking Revenue from Unfair Gouging (DRUG) Act would require pharmacy benefit managers that contract with a carrier offering federal health benefits plans to "de-link" the fees they charge insurers from the price of drugs.<br><br>

The Biden administration took the first step in its Medicare drug price negotiation program for 10 of the costliest prescription drugs, giving drugmakers until March 2 to either accept the government's offer or make a counteroffer.

23% of SMB CEOs anticipate handing out smaller pay raises than they did in 2023, and 4% don't plan to give any raises this year.

Though J&J is one of the country's largest drugmakers, the lawsuit argues, it failed to use its buying power when purchasing medications to negotiate the best prices for medicines for workers on its health plan.

A robust generative AI platform with the needed underpinnings around data and human capital enables benefit consultants to provide new and deeper answers and insights into the challenges the industry has faced as we have endeavored to both offset and manage continuously high cost of care and annual trends.